EUVIMEDEUVIMED entdecken
MetaanalyseSystematische Übersicht

Lithium Therapy’s Potential to Lower Dementia Risk and the Prevalence of Alzheimer’s Disease: A Meta-Analysis

Qiuying Lu, Huijing Lv, Xiaotong Liu, Lili Zang, Yue Zhang, Qinghui Meng

European Neurology · 2024 · 87 (2) · 93-104

DOI: 10.1159/000538846 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift European Neurology, online erschienen am 24.04.2024. Verfasst von Qiuying Lu und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Nursing, Shandong Second Medical University, Weifang, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Dementia. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Dementia is a neurodegenerative disease with insidious onset and progressive progression, of which the most common type is Alzheimer's disease (AD). Lithium, a trace element in the body, has neuroprotective properties. However, whether lithium can treat dementia or AD remains a highly controversial topic. Therefore, we conducted a meta-analysis.

Methods

A systematic literature review was conducted on PubMed, Embase, and Web of Science. Comparison of the effects of lithium on AD or dementia in terms of use, duration, and dosage, and meta-analysis to test whether lithium therapy is beneficial in ameliorating the onset of dementia or AD. Sensitivity analyses were performed using a stepwise exclusion method. The Newcastle-Ottawa Scale (NOS) was used to assess the quality of included studies. We determined the relative risk (RR) between patient groups using a random-effects model.

Results

A total of seven studies were included. The forest plot results showed that taking lithium therapy reduced the risk of AD (RR 0.59, 95% confidence interval [CI]: 0.44–0.78) and is also protective in reducing the risk of dementia (RR 0.66, 95% CI: 0.56–0.77). The duration of lithium therapy was able to affect dementia incidence (RR 0.70, 95% CI: 0.55–0.88); however, it is unclear how this effect might manifest in AD. It is also uncertain how many prescriptions for lithium treatment lower the chance of dementia development.

Conclusion

The duration of treatment and the usage of lithium therapy seem to lower the risk of AD and postpone the onset of dementia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseDementiaHumansLithium CompoundsPrevalenceLithiumNeuroprotective Agents

Stichwörter der Autor:innen

Alzheimer’s diseaseDementiaLithiumMeta-analysis

Substanzen

Lithium CompoundsLithiumNeuroprotective Agents

Autor:innen und Institutionen

  • School of Nursing, Shandong Second Medical University, Weifang, China.

Zitieren

APA

Lu, Q., Lv, H., Liu, X., Zang, L., Zhang, Y., & Meng, Q. (2024). Lithium Therapy’s Potential to Lower Dementia Risk and the Prevalence of Alzheimer’s Disease: A Meta-Analysis. European Neurology, 87(2), 93-104. https://doi.org/10.1159/000538846

Vancouver

Lu Q, Lv H, Liu X, Zang L, Zhang Y, Meng Q. Lithium Therapy’s Potential to Lower Dementia Risk and the Prevalence of Alzheimer’s Disease: A Meta-Analysis. European Neurology. 2024;87(2):93-104. doi:10.1159/000538846

BibTeX
@article{Lu2024,
  author = {Lu, Qiuying and Lv, Huijing and Liu, Xiaotong and Zang, Lili and Zhang, Yue and Meng, Qinghui},
  title = {Lithium Therapy’s Potential to Lower Dementia Risk and the Prevalence of Alzheimer’s Disease: A Meta-Analysis},
  journal = {European Neurology},
  year = {2024},
  volume = {87},
  number = {2},
  pages = {93--104},
  doi = {10.1159/000538846}
}
Kostenlos starten →